HOXA9 and leukemia: Overall, the expression of Meis1–3, Pbx1–3, and their associated partner, Hoxa9, were observed as upregulated in thymoma, pancreatic adenocarcinoma, glioblastoma, glioma, lymphoma, and leukemia when compared to corresponding healthy adult tissues (Figure 1).